Biotech company Cue Health is enacting a new cost-cutting strategy that will lead to the termination of 230 employees, constituting 49% of its workforce, according to documents filed with the U.S. Securities and Exchange Commission.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
